Lis E E London1, Arun H S Kumar2, Rebecca Wall3, Pat G Casey4, Orla O'Sullivan5, Fergus Shanahan3, Colin Hill4, Paul D Cotter1, Gerald F Fitzgerald4, R Paul Ross4, Noel M Caplice2, Catherine Stanton6. 1. Alimentary Pharmabiotic Centre, Teagasc, Food Research Centre Moorepark, Fermoy, Cork, Ireland. 2. Centre for Research in Vascular Biology, and. 3. Alimentary Pharmabiotic Centre. 4. Alimentary Pharmabiotic Centre, Department of Microbiology, University College Cork, Cork, Ireland; and. 5. Teagasc, Food Research Centre Moorepark, Fermoy, Cork, Ireland. 6. Alimentary Pharmabiotic Centre, Teagasc, Food Research Centre Moorepark, Fermoy, Cork, Ireland catherine.stanton@teagasc.ie.
Abstract
BACKGROUND: Probiotic bacteria have been associated with a reduction in cardiovascular disease risk, a leading cause of death and disability. OBJECTIVES: The aim of this study was to assess the impact of dietary administration of exopolysaccharide-producing probiotic Lactobacillus cultures on lipid metabolism and gut microbiota in apolipoprotein E (apoE)-deficient mice. METHODS: First, we examined lipid metabolism in response to dietary supplementation with recombinant β-glucan-producing Lactobacillus paracasei National Food Biotechnology Centre (NFBC) 338 expressing the glycosyltransferase (Gtf) gene from Pediococcus parvulus 2.6 (GTF), and naturally exopolysaccharide-producing Lactobacillus mucosae Dairy Product Culture Collection (DPC) 6426 (DPC 6426) compared with the non-β-glucan-producing isogenic control strain Lactobacillus paracasei NFBC 338 (PNZ) and placebo (15% wt:vol trehalose). Second, we examined the effects on the gut microbiota of dietary administration of DPC 6426 compared with placebo. Probiotic Lactobacillus strains at 1 × 10(9) colony-forming units/d per animal were administered to apoE(-/-) mice fed a high-fat (60% fat)/high-cholesterol (2% wt:wt) diet for 12 wk. At the end of the study, aortic plaque development and serum, liver, and fecal variables involved in lipid metabolism were analyzed, and culture-independent microbial analyses of cecal content were performed. RESULTS: Total cholesterol was reduced in serum (P < 0.001; ∼33-50%) and liver (P < 0.05; ∼30%) and serum triglyceride concentrations were reduced (P < 0.05; ∼15-25%) in mice supplemented with GTF or DPC 6426 compared with the PNZ or placebo group, respectively. In addition, dietary intervention with GTF led to increased amounts of fecal cholesterol excretion (P < 0.05) compared with all other groups. Compositional sequencing of the gut microbiota revealed a greater prevalence of Porphyromonadaceae (P = 0.001) and Prevotellaceae (P = 0.001) in the DPC 6426 group and lower proportions of Clostridiaceae (P < 0.05), Peptococcaceae (P < 0.001), and Staphylococcaceae (P < 0.01) compared with the placebo group. CONCLUSION: Ingestion of exopolysaccharide-producing lactobacilli resulted in seemingly favorable improvements in lipid metabolism, which were associated with changes in the gut microbiota of mice.
BACKGROUND: Probiotic bacteria have been associated with a reduction in cardiovascular disease risk, a leading cause of death and disability. OBJECTIVES: The aim of this study was to assess the impact of dietary administration of exopolysaccharide-producing probiotic Lactobacillus cultures on lipid metabolism and gut microbiota in apolipoprotein E (apoE)-deficient mice. METHODS: First, we examined lipid metabolism in response to dietary supplementation with recombinant β-glucan-producing Lactobacillus paracasei National Food Biotechnology Centre (NFBC) 338 expressing the glycosyltransferase (Gtf) gene from Pediococcus parvulus 2.6 (GTF), and naturally exopolysaccharide-producing Lactobacillus mucosae Dairy Product Culture Collection (DPC) 6426 (DPC 6426) compared with the non-β-glucan-producing isogenic control strain Lactobacillus paracasei NFBC 338 (PNZ) and placebo (15% wt:vol trehalose). Second, we examined the effects on the gut microbiota of dietary administration of DPC 6426 compared with placebo. Probiotic Lactobacillus strains at 1 × 10(9) colony-forming units/d per animal were administered to apoE(-/-) mice fed a high-fat (60% fat)/high-cholesterol (2% wt:wt) diet for 12 wk. At the end of the study, aortic plaque development and serum, liver, and fecal variables involved in lipid metabolism were analyzed, and culture-independent microbial analyses of cecal content were performed. RESULTS: Total cholesterol was reduced in serum (P < 0.001; ∼33-50%) and liver (P < 0.05; ∼30%) and serum triglyceride concentrations were reduced (P < 0.05; ∼15-25%) in mice supplemented with GTF or DPC 6426 compared with the PNZ or placebo group, respectively. In addition, dietary intervention with GTF led to increased amounts of fecal cholesterol excretion (P < 0.05) compared with all other groups. Compositional sequencing of the gut microbiota revealed a greater prevalence of Porphyromonadaceae (P = 0.001) and Prevotellaceae (P = 0.001) in the DPC 6426 group and lower proportions of Clostridiaceae (P < 0.05), Peptococcaceae (P < 0.001), and Staphylococcaceae (P < 0.01) compared with the placebo group. CONCLUSION: Ingestion of exopolysaccharide-producing lactobacilli resulted in seemingly favorable improvements in lipid metabolism, which were associated with changes in the gut microbiota of mice.
Authors: Tiffany M Newman; Carol A Shively; Thomas C Register; Susan E Appt; Hariom Yadav; Rita R Colwell; Brian Fanelli; Manoj Dadlani; Karlis Graubics; Uyen Thao Nguyen; Sivapriya Ramamoorthy; Beth Uberseder; Kenysha Y J Clear; Adam S Wilson; Kimberly D Reeves; Mark C Chappell; Janet A Tooze; Katherine L Cook Journal: Microbiome Date: 2021-05-05 Impact factor: 14.650
Authors: Paul M Ryan; Caitriona M Guinane; Lis E E London; Philip R Kelleher; Gerald F Fitzgerald; Noel M Caplice; R Paul Ross; Catherine Stanton Journal: Genome Announc Date: 2015-01-15
Authors: Maria Kulecka; Agnieszka Paziewska; Natalia Zeber-Lubecka; Filip Ambrozkiewicz; Michal Kopczynski; Urszula Kuklinska; Kazimiera Pysniak; Marta Gajewska; Michal Mikula; Jerzy Ostrowski Journal: Nutr Metab (Lond) Date: 2016-08-23 Impact factor: 4.169
Authors: Tariq Jamal Khan; Youssri M Ahmed; Mazin A Zamzami; Saleh A Mohamed; Imran Khan; Othman A S Baothman; Mohamed G Mehanna; Muhammad Yasir Journal: Sci Rep Date: 2018-01-12 Impact factor: 4.379